Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	May 31, 2025	May 31, 2024
Cash Flows From Operating Activities:
Net income (loss) available to common shareholders	$ 170,908	$ (36,796)
Series A Preferred Stock Dividends	0	1,200
Plus: Redemption premium on Series A Preferred Stock	0	75,198
Net income	170,908	39,602
Adjustments to reconcile net income to net cash provided by operating activities:
Bad debt expense	320	330
Depreciation and amortization	21,827	20,323
Deferred income taxes	(4,056)	3,164
Equity in earnings of unconsolidated entities	(173,523)	(3,824)
Distribution on investment in AVAIL joint venture	273,223	539
Restructuring charges	3,744	0
Net gain on sale of property, plant and equipment	(2,686)	(16)
Amortization of debt financing costs	3,198	3,109
Share-based compensation expense	5,086	2,535
Changes in current assets and current liabilities	17,768	7,610
Changes in other long-term assets and long-term liabilities	(1,027)	(1,428)
Net cash provided by operating activities	314,782	71,944
Cash flows from investing activities
Purchase of property, plant and equipment	(20,896)	(27,396)
Proceeds from sale of property, plant and equipment	3,774	17
Net cash used in investing activities	(17,122)	(27,379)
Cash flows from financing activities:
Proceeds from issuance of common stock	0	308,723
Redemption of Series A Preferred Stock	0	(308,920)
Tax payments related to common stock issued under stock-based plans	(4,598)	(4,567)
Proceeds from Revolving Credit Facility	210,000	75,000
Payments on Revolving Credit Facility	(160,000)	(70,000)
Payments of debt financing costs	(20)	(715)
Payments on long term debt and finance leases	(335,809)	(30,196)
Payments of dividends	(5,085)	(7,867)
Net cash used in financing activities	(295,512)	(38,542)
Effect of exchange rate changes on cash	(593)	174
Net increase in cash and cash equivalents	1,555	6,197
Cash and cash equivalents at beginning of period	1,488	4,349
Cash and cash equivalents at end of period	$ 3,043	$ 10,546